Type 2 diabetes mellitus: a disease of the innate immune system? An update

被引:124
作者
Crook, M [1 ]
机构
[1] Univ Hosp Lewisham, London SE13 6LH, England
关键词
acute phase response; complications; C-reactive protein; diabetes; inflammation; insulin resistance; sialic acid;
D O I
10.1046/j.1464-5491.2003.01030.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A few years ago a hypothesis was proposed suggesting that elements of the innate immune system, such as acute phase reactants, contribute to the development of Type 2 diabetes mellitus. Acute phase reactants such as C-reactive protein and sialic acid may thus predict risk of developing Type 2 diabetes mellitus, as well as being markers of diabetes microvascular and macrovascular complications. This article discusses these issues.
引用
收藏
页码:203 / 207
页数:5
相关论文
共 90 条
  • [1] Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study
    Albert, MA
    Danielson, E
    Rifai, N
    Ridker, PM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01): : 64 - 70
  • [2] The relation of markers of inflammation to the development of glucose disorders in the elderly - The cardiovascular health study
    Barzilay, JI
    Abraham, L
    Heckbert, SR
    Cushman, M
    Kuller, LH
    Resnick, HE
    Tracy, RP
    [J]. DIABETES, 2001, 50 (10) : 2384 - 2389
  • [3] Novel clinical markers of vascular wall inflammation
    Blake, GJ
    Ridker, PM
    [J]. CIRCULATION RESEARCH, 2001, 89 (09) : 763 - 771
  • [4] INSULIN IS A PROMINENT MODULATOR OF THE CYTOKINE-STIMULATED EXPRESSION OF ACUTE-PHASE PLASMA-PROTEIN GENES
    CAMPOS, SP
    BAUMANN, H
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (04) : 1789 - 1797
  • [5] C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites
    Chambers, JC
    Eda, S
    Bassett, P
    Karim, Y
    Thompson, SG
    Gallimore, JR
    Pepys, MB
    Kooner, JS
    [J]. CIRCULATION, 2001, 104 (02) : 145 - 150
  • [6] Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy
    Chen, JW
    Gall, MA
    Yokoyama, H
    Jensen, JS
    Deckert, M
    Parving, HH
    [J]. DIABETES CARE, 1996, 19 (02) : 130 - 134
  • [7] CHERNOFF AE, 1995, J IMMUNOL, V154, P5492
  • [8] Growth hormone (GH) replacement therapy reduces serum sialic acid concentrations in adults with GH-deficiency:: a double-blind placebo-controlled study
    Christ, ER
    Cummings, MH
    Lumb, PJ
    Crook, MA
    Sönksen, PH
    Russell-Jones, DL
    [J]. CLINICAL ENDOCRINOLOGY, 1999, 51 (02) : 173 - 179
  • [9] Pro-inflammatory cytokines and adipose tissue
    Coppack, SW
    [J]. PROCEEDINGS OF THE NUTRITION SOCIETY, 2001, 60 (03) : 349 - 356
  • [10] Serum sialic acid, a reputed cardiovascular risk factor, is elevated in South Asian men compared to European men
    Crook, M
    Kerai, P
    Andrews, V
    Lumb, P
    Swaminathan, R
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 1998, 35 : 242 - 244